Itraconazole in the treatment of superficial cutaneous and mucosal Candida infections

Journal of the American Osteopathic Association

Volumn 98, Issue 9, 1998, Pages 497-502

  Del Rosso, James Q ^a,d   Zellis, Sharon ^b,c   Gupta, Aditya K ^d  

^a UNIVERSITY OF NEVADA   (United States)

^b PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^c University of Toronto ^*

^d Las Vegas Skin & Cancer Clinics Ltd   (United States)

Author keywords

'Pulse' or intermittent therapy; Antifungal agents; Candida infections

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE;

ANTIFUNGAL ACTIVITY; CANDIDA; CANDIDIASIS; DRUG EFFECT; DRUG SAFETY; HUMAN; MUCOSA INFLAMMATION; NAIL DISEASE; ONYCHOMYCOSIS; ORAL DRUG ADMINISTRATION; PARONYCHIA; REVIEW; SKIN INFECTION; VAGINA CANDIDIASIS;

ANTIFUNGAL AGENTS; CANDIDIASIS; CANDIDIASIS, CUTANEOUS; HUMANS; ITRACONAZOLE;

EID: 0031658470     PISSN: 00986151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Mooney MA. Oral candidosis. Int J Dermatol 1995;34:759-765.
2. Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E, Trautmann M. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J Clin Microbiol 1994;32:2092-2098.
3. Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995;39:1-8.
4. Grant SM, Clissold SP. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs 1989;37:310-344.
5. De Doncker P, Gupta AK, Marynissen G, Stoffels P, Heremans A. Itraconazole pulse therapy for onychomycosis and dermatomycoses: An overview. J Am Acad Dermatol 1997;37:969-974.
6. Cauwenbergh G, De Doncker P, Stoops K, De Dier AM, Goyvaerts H, Schuermans V. Itraconazole in the treatment of human mycoses: Review of three years of clinical experience. Rev Infect Dis 1987;9(suppl 1):S146-S152.
7. Sporanox (Itraconazole) Oral Solution. United States Product Monograph. Titusville, NJ: Janssen Pharmaceutica; 1997. Data on file.
8. Pierard GE, Arrese JE, De Doncker P. Antifungal activity of itraconazole and terbinafine in human stratum comeum, a comparative study. J Am Acad Dermatol 1995;32:429-435.
9. Greer DL. Evolving role of nondermatophytes in onychomycosis. Int J Demratol 1995;34:521-524.
10. Hay RJ. Antifungal therapy of yeast infections. J Am Acad Dermatol 1994;31 (3 pt 2):S6-S9.
11. Daniel CR Ill. Nonfungal infectons. In: Scher RK, Daniel CR Ill. Nails: Therapy, Diagnosis, Surgery, 1st ed. Philadelphia, Pa: WB Saunders Co;1990;pp 120-126.
12. Rashid A, De Doncker P. Itraconazole 1-week pulse therapy in the management of Candida paronychia. Poster presented at the 19th World Congress of Dermatology; June 15-20, 1997; Sydney, Australia.
13. Hay RJ, Baran R, Moore MK, Wilkinson JD. Candida onychomycosis - an evaluation of the role of Candida species in nail disease. Br J Dermatol 1988;118:47-58.
14. Hay RJ, Clayton YM, Moore MK, Midgely G. An evaluation of itraconazole in the management of onychomycosis. Br J Dermatol 1988;119(3):359-366.
15. Gupta AK, Scher RK. Management of onychomycosis: a North American perspective. Dermatologic Therapy 1997;3:58-65.
16. Segal R, Kritzman A, Cividalli L, Samra Z, David M, Tiqva P. Treatment of Candida nail infection with terbinafine. J Am Acad Dermatol 1996;35:958-961.
17. Kim JA, Ahn KJ, Kim JM. Efficacy and tolerability of itraconazole in patients with fingernail onychomycosis: A 6 week pilot study. Curr Ther Res 1995;56:1066-1075.
18. UWD, Ping WA, Yu LR, Want R, De Doncker P, Heremans A. Therapeutic efficacy of intermittent pulse therapy with itraconazole in onychomycosis: a Chinese multicenter trial. Poster presented at the 54th Annual Meeting of the American Academy of Dermatology; February, 1996; Washington, DC, USA.
19. Tosti A, Piraccini BM, Vincenzi C, Cameli N. Itraconazole in the treatment of two young brothers with chronic mucocutaneous candidiasis. Pediatr Dermatol 1997;14(2):146-148.
20. DePadova-Elder SM, Ditre CM, Kantor GR, Koblenzer PJ. Candidiasis endocrinopathy syndrome. Treatment with itraconazole. Arch Dermatol 1994;130:19-22.
21. Stein GE, Mummaw N. Placebo-controlled trial of itraconazole for treatment of acute vaginal candidiasis. Antimicrob Agents Chemother 1993;37:89-92.
22. Roongpisuthipong A, Bhiraleus P, Sukroongreung S, Sentrakul P, Papaibul K, Dusitsin N. Itraconazole in the treatment of acute vaginal candidosis. J Med Assoc Thai 1992;75(1):30-34.
23. Fong IW, Bannatyne RM, Wong P. Lack of in vitro resistance of Candida albicans to ketoconazole, itraconazole and clotrimazole in women treated for recurrent vaginal candidiasis. Genitourin Med 1993;69:44-46.
24. Fong IW. The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal candidiasis. Genitourin Med 1992;68:374-377.
25. Del Rosso JQ. Drug interactions of significance to dermatologists. Presented at the American Academy of Dermatology Mid-year meeting, July-August, 1997; New York, NY.